About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

TAIKO PHARMACEUTICAL CO., LTD.(4574) Financial Results

4574
TSE Prime
TAIKO PHARMACEUTICAL CO., LTD.
309
JPY
-11
(-3.44%)
Jan 14, 3:30 pm JST
1.96
USD
Jan 14, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2020 Changed 17,582 5,650 5,454 3,851 89.2 25 Feb 12, 2021 J-GAAP
Dec, 2021 11,299 -4,947 -6,131 -9,594 -220.5 0 Feb 18, 2022 J-GAAP
Dec, 2022 5,040 -3,079 -3,352 -4,895 -112.3 0 Feb 10, 2023 J-GAAP
Dec, 2023 6,120 -1,005 -1,248 -3,611 -76.3 0 Feb 9, 2024 J-GAAP
Dec, 2024 Guidance 6,800 550 590 550 11.0 Aug 9, 2024 J-GAAP
YoY +11.1%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 14,966 3,824 3,633 2,453 57.6
Fiscal Year Mar, 2020 Mar, 2020 Mar, 2020 Mar, 2020 Mar, 2020
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2021 6,193 -2,667 -3,394 -7,222 -166.0 0 Feb 18, 2022 J-GAAP
Jul - Dec, 2022 3,183 -662 -837 -2,097 -48.1 0 Feb 10, 2023 J-GAAP
Jul - Dec, 2023 3,632 -609 -738 -3,097 -65.4 0 Feb 9, 2024 J-GAAP
Jul - Dec, 2024 Guidance 3,940 68 62 -214 -4.3 Aug 9, 2024 J-GAAP
YoY +8.5% +93.1% +93.5%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Dec, 2021 -4,947 -3,217 -1,595 -1,622 3,959 5,521 24.50 J-GAAP
Dec, 2022 -3,079 -1,804 -1,994 190 -997 2,797 18.59 J-GAAP
Dec, 2023 -1,005 859 -307 1,166 1,539 5,244 39.67 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 3,389 -2,750 -2,898 -3,182 -73.0 Nov 11, 2022 J-GAAP
Jan - Sep, 2023 4,417 -444 -589 -562 -12.1 Nov 10, 2023 J-GAAP
Jan - Sep, 2024 4,579 726 705 714 14.2 119.5 Nov 8, 2024 J-GAAP
YoY +3.7%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 1,651 -329 -454 -1,713 -39.3 -19.9 Feb 10, 2023 J-GAAP
Jan - Mar, 2023 1,167 -155 -242 -243 -5.6 -13.3 May 12, 2023 J-GAAP
Apr - Jun, 2023 1,321 -241 -268 -271 -6.0 -18.2 Aug 10, 2023 J-GAAP
Jul - Sep, 2023 1,929 -48 -79 -48 -1.0 -2.5 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 1,703 -561 -659 -3,049 -64.4 -32.9 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 1,377 214 229 472 9.4 15.5 May 10, 2024 J-GAAP
Apr - Jun, 2024 1,483 268 299 292 5.8 18.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 1,719 244 177 -50 -1.0 14.2 Nov 8, 2024 J-GAAP
YoY -10.9% -4.2% +2.9%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 6,615 2,757 2,702 1,870 43.6
Fiscal Year Dec, 2020 Jun, 2020 Jun, 2020 Jun, 2020 Jun, 2020
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Dec, 2021 293.88 56.8 22,535 12,807 10,134 0.37 Feb 18, 2022 J-GAAP
Dec, 2022 184.60 53.5 15,046 8,044 5,239 0.47 Feb 10, 2023 J-GAAP
Dec, 2023 134.93 51.0 13,220 6,739 1,628 0.48 Feb 9, 2024 J-GAAP
Jan - Sep, 2024 61.4 13,137 8,064 2,343 0.28 Nov 8, 2024 J-GAAP